Chemed Corp (CHE)
NYSE · Healthcare · Medical Care Facilities
Chemed Corp is a Healthcare company with a market capitalization of $7.06B, a trailing P/E ratio of 27.1, and a dividend yield of 0.34%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 28, 2026 | $5.52 | $5.12 | +7.8% |
| Q1 2026 | April 23, 2026 | $5.65 | $5.30 | +6.6% |
| Q4 2025 | February 25, 2026 | $6.42 | $7.07 | -9.2% |
| Q3 2025 | October 28, 2025 | $5.27 | $5.37 | -1.9% |
| Q2 2025 | July 29, 2025 | $4.27 | $4.98 | -14.3% |
| Q1 2025 | April 23, 2025 | $5.63 | $5.55 | +1.4% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 566,002 | 4.14% | 3.6 | +0.3% |
| June 30, 2026 | 564,257 | 4.13% | 2.3 | -6.3% |
| June 15, 2026 | 602,352 | 4.40% | 2.8 | -5.5% |
| May 29, 2026 | 637,297 | 4.66% | 3.2 | +1.1% |
| May 15, 2026 | 630,541 | 4.61% | 2.7 | +20.1% |
| April 30, 2026 | 525,042 | 3.84% | 1.7 | +22.0% |
| April 15, 2026 | 430,383 | 3.08% | 2.1 | -11.8% |
| March 31, 2026 | 487,863 | 3.49% | 1.5 | +13.2% |
Other Medical Care Facilities Stocks
Frequently Asked Questions
What is Chemed Corp's market cap?
As of August 13, 2026, Chemed Corp (CHE) has a market capitalization of $7.06B.
What is Chemed Corp's P/E ratio?
Chemed Corp trades at a trailing price-to-earnings (P/E) ratio of 27.1. Its forward P/E is 21.9.
Does Chemed Corp pay a dividend?
Yes — Chemed Corp pays a dividend yielding 0.34%, an annual payout of $2.40 per share.
What sector is CHE in?
Chemed Corp is in the Healthcare sector, specifically the Medical Care Facilities industry.
What is Chemed Corp's short interest?
As of the July 15, 2026 FINRA settlement, 566,002 CHE shares were sold short, or 4.14% of shares outstanding. Days to cover: 3.6. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Chemed Corp's revenue?
In its latest reported fiscal year (ending December 31, 2025), Chemed Corp reported revenue of $2.53B and net income of $265.24M.
Ask your own questions about CHE
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.